Corbus Pharmaceuticals (CRBP) PT Lowered to $58 at RBC Capital
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Price: $10.09 +0.10%
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
RBC Capital analyst Brian Abrahams lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $58.00 (from $65.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Corbus Pharmaceuticals (CRBP) PT Lowered to $33 at Mizuho
- Petronet LNG Ltd. (PLNG:IN) PT Raised to INR310 at ICICI Securities
- Diversified Royalty Corp (DIV:CN) (BEVFF) PT Lowered to Cdn$4.75 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
